| 2008 Aug |
Signed exclusive licensing rights for Aethoxysklerol®, a sclerotherapy agent for the treatment of varicose veins, a much needed treatment option in China |
| 2008 July |
Appointed Eisai China Inc. as the marketing agent for Alpha Lipon®, a
company with a focus in endocrinology |
| 2007 Oct |
Full launch of FibinGluRAAS® with the set up of a specialist team
Health Vision (Nan Jing) Medicine Company Limited obtains GSP license |
2007 Mar
2007 Apr |
Obtain exclusive marketing agreement with Shanghai RAAS for their
innovative haemostatic product, FibinGluRAAS®, a dual syringe
containing fibrinogen and thrombin
Obtain business license for Health Vision (Nan Jing) Medicine company, a
wholly foreign owned enterprise allowing importation, logistic
distribution and licensing-in products |
| 2005 May |
Stada acquires operations of Beijing Center-Lab Pharmaceuticals Ltd. to
strengthen operation in China |
| 2005 Jan |
Launched the most powerful oxidative stress inhibitor – Alpha-Lipon® (alpha lipoic acid) for the treatment of diabetic neuropathy |
| 2004 Sept |
Azelastine nasal spray listed on the State Drug List for reimbursement |
| 2004 July |
Launched the fastest acting treatment for allergic rhinitis – Azep®
(azelastine HCl) Nasal Spray |
| 2001 |
Merged with STADA to become Health Vision Enterprise (HVE) Ltd
Established Health Vision Consulting (Shanghai) Ltd, a wholly foreign
owned enterprise |
| 2000 |
Added Gelomyrtol® Forte children's strength to the portfolio |
| 1999 |
Gelomyrtol® Forte listed in the top 200 pharmaceutical producs (IMS) |
| 1997 |
Launched Gelomyrtol® Forte for the treatment of sinusitis and bronchitis |
| 1996 |
Entered China with the establishment of Representative offices in
Beijing, Shanghai and Guangzhou. Launched Nitro lingual Spray® |
| 1995 |
Health Vision (HK) Ltd – founded by Zona Yim and Alex Leung in Hong
Kong.
<< Click here for more >> |